3D Bioprinting in Pharma: A Deep Dive into Uses, IP in Allogeneic/Autologous, Cell Therapy, Organoids, and Scaffold Delivery
In today’s booming pharma market, 3D bioprinting stands as a game – changer, with a 2023 SEMrush study predicting it’ll…
Category: Pharmaceutical Patent Litigation
Unveiling the IP Landscape: Clean Room Manufacturing, Genetically Engineered Cell Lines, Plasmid DNA Synthesis, Vector Production, and Viral Vector Purification
In the rapidly evolving biotech sector, understanding the IP landscape of clean room manufacturing, genetically engineered cell lines, plasmid DNA…
FRAND Licensing in Pharma: Implications, Disputes, and Its Synergy with Open COVID Pledge Impact
Looking for the best FRAND licensing solutions in the pharmaceutical industry? Don’t miss this exclusive buying guide! Recent SEMrush 2023…
AI – Driven Prior Art Searches, CEPIATM Exemptions, and Their Impact on Drug Pricing, Patent Litigation & ANDA Jury Verdicts
In the dynamic world of pharmaceuticals, AI – driven prior art searches, CEPIATM exemptions, foreign patent litigations, and ANDA jury…
Unveiling the World of Autoinjector, Lyophilization, Prefilled Syringe, Sterile Packaging, and Vial Closure System IP: From Patents to Market Impact
Are you looking to invest in cutting – edge medical IP? Our exclusive buying guide dives into the world of…
Navigating the Complex Landscape of Amorphous Dispersion, Co – crystal, Excipient, Polymorph, and Prodrug IP: Recent Patent Law Changes
In the ever – evolving pharmaceutical landscape, recent patent law changes are reshaping the game for amorphous dispersion, co –…